ICI 192605 is a potent antagonist of the thromboxane A<sub>2</sub> receptor (TP) that blocks contraction of isolated guinea pig trachea induced by U-46619 (Item No. 16450 K<sub>d</sub> = 0.
ICI 192605 is a potent antagonist of the thromboxane A<sub>2</sub> receptor (TP) that blocks contraction of isolated guinea pig trachea induced by U-46619 (Item No. 16450 K<sub>d</sub> = 0.
ICI 192605 is a potent antagonist of the thromboxane A<sub>2</sub> receptor (TP) that blocks contraction of isolated guinea pig trachea induced by U-46619 (Item No. 16450 K<sub>d</sub> = 0.
ICI 192605 is a potent antagonist of the thromboxane A<sub>2</sub> receptor (TP) that blocks contraction of isolated guinea pig trachea induced by U-46619 (Item No. 16450 K<sub>d</sub> = 0.
A reversible, ATP-competitive inhibitor of CK1&delta and CK1? (IC<sub>50</sub> = ~1 µM for both), as well as CK1&alpha (IC<sub>50</sub> = 16 µM) at 1 µM, inhibits cytokinesis in primary mouse embryo fibroblasts used to
A reversible, ATP-competitive inhibitor of CK1&delta and CK1? (IC<sub>50</sub> = ~1 µM for both), as well as CK1&alpha (IC<sub>50</sub> = 16 µM) at 1 µM, inhibits cytokinesis in primary mouse embryo fibroblasts used to
ICI 192605 is a potent antagonist of the thromboxane A<sub>2</sub> receptor (TP) that blocks contraction of isolated guinea pig trachea induced by U-46619 (Item No. 16450 K<sub>d</sub> = 0.
ICI 192605 is a potent antagonist of the thromboxane A<sub>2</sub> receptor (TP) that blocks contraction of isolated guinea pig trachea induced by U-46619 (Item No. 16450 K<sub>d</sub> = 0.
A potent, selective, and orally bioavailable inhibitor of PI3K&gamma and PI3K&delta (IC<sub>50</sub>s = 0.24 and 50 nM, respectively) has profound effects in collagen-induced and adjuvant-induced arthritis, ovalbumin-induced asthma, and systemic
A potent, selective, and orally bioavailable inhibitor of PI3K&gamma and PI3K&delta (IC<sub>50</sub>s = 0.24 and 50 nM, respectively) has profound effects in collagen-induced and adjuvant-induced arthritis, ovalbumin-induced asthma, and systemic
A potent, cell-permeable inhibitor of the tyrosine kinase activity of the epidermal growth factor (EGF) receptor (IC<sub>50</sub> = 0.45 nM) effective in cells, blocking tyrosine phosphorylation induced by either EGF or heregulin (IC<sub>50</sub>s
A potent, cell-permeable inhibitor of the tyrosine kinase activity of the epidermal growth factor (EGF) receptor (IC<sub>50</sub> = 0.45 nM) effective in cells, blocking tyrosine phosphorylation induced by either EGF or heregulin (IC<sub>50</sub>s
ICI 192605 is a potent antagonist of the thromboxane A<sub>2</sub> receptor (TP) that blocks contraction of isolated guinea pig trachea induced by U-46619 (Item No. 16450 K<sub>d</sub> = 0.
ICI 192605 is a potent antagonist of the thromboxane A<sub>2</sub> receptor (TP) that blocks contraction of isolated guinea pig trachea induced by U-46619 (Item No. 16450 K<sub>d</sub> = 0.